203 related articles for article (PubMed ID: 12803736)
1. The development of an oral antidiabetic combination tablet: design, evaluation and clinical benefits for patients with type 2 diabetes.
Howlett H; Porte F; Allavoine T; Kuhn T; Nicholson G
Curr Med Res Opin; 2003; 19(3):218-25. PubMed ID: 12803736
[TBL] [Abstract][Full Text] [Related]
2. [Formulation by design of experiments of immediate release tablets with metformin hydrochloride and glibenclamide].
Potur RG; Gafiţanu E
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1219-26. PubMed ID: 21500483
[TBL] [Abstract][Full Text] [Related]
3. Glyburide/metformin tablets: a new therapeutic option for the management of Type 2 diabetes.
Dailey GE
Expert Opin Pharmacother; 2003 Aug; 4(8):1417-30. PubMed ID: 12877648
[TBL] [Abstract][Full Text] [Related]
4. Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes.
Raskin P
Diabetes Obes Metab; 2008 Dec; 10(12):1167-77. PubMed ID: 18494804
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the pharmacokinetic and pharmacodynamic interactions between memantine and glyburide/metformin in healthy young subjects: a single-center, multiple-dose, open-label study.
Rao N; Chou T; Ventura D; Abramowitz W
Clin Ther; 2005 Oct; 27(10):1596-606. PubMed ID: 16330295
[TBL] [Abstract][Full Text] [Related]
6. Fixed-dose single tablet antidiabetic combinations.
Bailey CJ; Day C
Diabetes Obes Metab; 2009 Jun; 11(6):527-33. PubMed ID: 19175373
[TBL] [Abstract][Full Text] [Related]
7. Pioglitazone, rosiglitazone, and rosiglitazone + metformin: new drugs. Glitazone + oral antidiabetic combination: inadequately evaluated.
Prescrire Int; 2005 Aug; 14(78):133-9. PubMed ID: 16106595
[TBL] [Abstract][Full Text] [Related]
8. Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure.
Kokić S; Buković D; Radman M; Capkun V; Gabrić N; Lesko V; Karelović D; Stancerić T
Coll Antropol; 2003 Jun; 27(1):181-7. PubMed ID: 12974145
[TBL] [Abstract][Full Text] [Related]
9. The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes).
Kardas P
Diabetes Obes Metab; 2005 Nov; 7(6):722-8. PubMed ID: 16219016
[TBL] [Abstract][Full Text] [Related]
10. Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy.
Bell DS
Clin Ther; 2004 Nov; 26(11):1714-27. PubMed ID: 15639686
[TBL] [Abstract][Full Text] [Related]
11. Oral antidiabetic agents in pregnancy and lactation: a paradigm shift?
Feig DS; Briggs GG; Koren G
Ann Pharmacother; 2007 Jul; 41(7):1174-80. PubMed ID: 17535842
[TBL] [Abstract][Full Text] [Related]
12. Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase-4 inhibitor sitagliptin when co-administered in patients with type 2 diabetes.
Herman GA; Bergman A; Yi B; Kipnes M;
Curr Med Res Opin; 2006 Oct; 22(10):1939-47. PubMed ID: 17022853
[TBL] [Abstract][Full Text] [Related]
13. Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents.
Goodarzi MO; Bryer-Ash M
Diabetes Obes Metab; 2005 Nov; 7(6):654-65. PubMed ID: 16219009
[TBL] [Abstract][Full Text] [Related]
14. [Could oral antidiabetic agents be useful in the management of different types of diabetes and syndromes of insulin resistance in children and adolescents?].
Otto-Buczkowska E; Nowowiejska B; Jarosz-Chobot P; Stańczyk J
Przegl Lek; 2009; 66(7):388-93. PubMed ID: 20043582
[TBL] [Abstract][Full Text] [Related]
15. Saxagliptin, a potent, selective inhibitor of DPP-4, does not alter the pharmacokinetics of three oral antidiabetic drugs (metformin, glyburide or pioglitazone) in healthy subjects.
Patel CG; Kornhauser D; Vachharajani N; Komoroski B; Brenner E; Handschuh del Corral M; Li L; Boulton DW
Diabetes Obes Metab; 2011 Jul; 13(7):604-14. PubMed ID: 21332626
[TBL] [Abstract][Full Text] [Related]
16. A comparison of costs for four oral antidiabetic regimens within a managed care population.
Stockl K; Vanderplas AM; Nicklasson L
Manag Care Interface; 2003 Jul; 16(7):31-6. PubMed ID: 12908215
[TBL] [Abstract][Full Text] [Related]
17. [Antidiabetic fixed-dose combination tablet for the management of type 2 diabetes].
Sakane N
Nihon Rinsho; 2012 Jan; 70(1):165-70. PubMed ID: 22413513
[TBL] [Abstract][Full Text] [Related]
18. Sitagliptin: a novel drug for the treatment of type 2 diabetes.
Choy M; Lam S
Cardiol Rev; 2007; 15(5):264-71. PubMed ID: 17700385
[TBL] [Abstract][Full Text] [Related]
19. Comparison of glycaemic control in patients with Type 2 diabetes on basal insulin and fixed combination oral antidiabetic treatment: results of a pilot study.
De Mattia G; Laurenti O; Moretti A
Acta Diabetol; 2009 Mar; 46(1):67-73. PubMed ID: 19030772
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of once- or twice-daily extended release metformin compared with thrice-daily immediate release metformin in type 2 diabetes mellitus.
Bhansali A; Masoodi SR
J Assoc Physicians India; 2005 May; 53():441-5. PubMed ID: 16124352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
